Advanced-Stage Primary Cutaneous T-Cell Lymphoma Treated with Bexarotene and Denileukin Diftitox

Advanced-Stage Primary Cutaneous T-Cell Lymphoma Treated with Bexarotene and Denileukin Diftitox

Advanced-stage primary cutaneous T-cell lymphoma has an unfavorable prognosis and low survival rates. Aggressive treatment with chemotherapy is not curative and causes considerable side effects. The combination of bexarotene and denileukin diftitox is associated with an acceptable safety profile and...

Full description

Bibliographic Details
Main Authors: Iván Cervigón-González, Luis Miguel Torres-Iglesias, Ángel Palomo-Arellano, Braulio Gil-Pascual
Format: Article
Language:English
Published: Karger Publishers 2011-02-01
Series:Case Reports in Dermatology
Subjects:
Cutaneous T-cell lymphoma
Mycosis fungoides
Bexarotene
Denileukin diftitox
Online Access:http://www.karger.com/Article/FullText/324185

Internet

http://www.karger.com/Article/FullText/324185

Similar Items